Breaking

Mozambique’s top court confirms ruling party win in disputed election
Venezuelan opposition members say they’re under ‘siege’ as they take refuge in an embassy
Drug lord Fabio Ochoa walks free in Colombia after 20 years in US prisons
Burt, the huge Australian crocodile who had a cameo in ‘Crocodile Dundee,’ dies at 90
Driver who plowed into school crowd in southern China given suspended death sentence
The most – and least – surprising votes from a historic year of elections
Christians in Middle East celebrate Christmas under the shadow of instability and war
At least 12 killed in blast at explosives factory in Turkey

Business
World
Investing
Politics
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Element79 Announces Payment Extension Agreement for Lucero Project

December 24, 2024

Skyharbour Partner Company Terra Clean Energy Signs Exploration Agreement with the English River First Nation and Receives Drilling Permits for the South Falcon East Uranium Project

December 24, 2024

Lode Gold Announces $350,000 Non-Brokered Financing

December 24, 2024

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (200)
- Investing (729)
- Politics (878)
- World (821)

Disclaimer: ventureblessing.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2024 ventureblessing.com | All Rights Reserved

Top

Business
World
Investing
Politics

Type above and press Enter to search. Press Esc to cancel.